The NDRC designated Chengdu as one of four national pilot cities in February 2026 to stimulate industrial innovation vitality.
From $9/month · 7-day free trial
Already a subscriber? Log in
Beijing has launched a five-year campaign to expand domestic mineral discovery and extraction, backed by 500 billion yuan invested in the 2021–2025 cycle.
Ten government agencies jointly published China's pharmaceutical industry roadmap on September 21, 2026, setting a 20%+ annual growth target for innovative drugs and aiming for Chinese-developed first-in-class drugs to represent more than 25% of global new drug approvals by 2030.
China expanded its precursor chemical export licensing catalogue on 22 September 2026, adding two piperidine-derivative compounds with fentanyl precursor relevance.
Subscribe for full access to all articles
Start Free Trial